Myocardial Infarction
📧 Sign up to get email alerts when something new happens for Myocardial Infarction.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-09-25Clinical Trial Update: Rapid Activity of Platelet Inhibitor Drugs Study 2 [Phase 4]
A Phase 4 clinical trial update indicating that Study 2, evaluating rapid activity of platelet inhibitor drugs, has completed in patients wi…
-
CLINICAL_TRIALS research · 2014-09-19Clinical Trial Update: Heart Rate and Cardiovascular Diseases Prognosis in People With Stable Coronary Artery Disease
Clinical trial update examining the relationship between heart rate and prognosis across multiple cardiovascular conditions in people with s…
-
FDA approval · 2014-09-15FDA Approved: CLOPIDOGREL BISULFATE — Original Application (RADHA PHARMACEUTICALS, INC.)
FDA approved the original ANDA for clopidogrel bisulfate, a generic antiplatelet agent, expanding access to a therapy that reduces vascular …
-
CLINICAL_TRIALS trial_result · 2014-09-15Clinical Trial Update: Pilot Study of Edaravone to Treat Acute Myocardial Infarction [Phase 4]
This update reports results from a Phase 4 pilot trial of edaravone to treat acute myocardial infarction, including reperfusion injury.
-
CLINICAL_TRIALS trial_result · 2014-09-10Clinical Trial Update: A Study of Pre-hospital Treatment of Acute Myocardial Infarction Based on Diagnosis by Interpretation of Remotely Acquired ECG and Thrombolysis With Accelerated Alteplase ( Actilyse®)
A pre-hospital treatment trial for acute myocardial infarction using accelerated alteplase (Actilyse) based on remote ECG interpretation has…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-09-09Clinical Trial Update: Nesiritide Therapy to Preserve Function of the Left Ventricle After Myocardial Infarction [Phase 2]
Phase 2 trial results evaluating nesiritide therapy to preserve left ventricular function after acute myocardial infarction.
-
CLINICAL_TRIALS trial_result · 2014-09-09Clinical Trial Update: Sevoflurane In Acute Myocardial Infarction [Phase 2]
This document reports a Phase 2 clinical trial evaluating sevoflurane in patients with acute myocardial infarction that has completed, spons…
-
CLINICAL_TRIALS research · 2014-09-09Clinical Trial Update: Fractional Flow Reserve (FFR) Stability in Non-Culprit Vessels at ST Elevation Myocardial Infarction(STEMI) [NA]
A completed clinical trial update studying fractional flow reserve stability in non-culprit coronary vessels during ST-elevation myocardial …
-
EMA withdrawal · 2014-09-08EMA Withdrawn: Clopidogrel Qualimed (clopidogrel (as hydrochloride)) — Qualimed
EMA withdrew Clopidogrel Qualimed (clopidogrel hydrochloride) from the market.
-
CLINICAL_TRIALS trial_result · 2014-09-08Clinical Trial Update: Ticagrelor and Clopidogrel on Reperfusion in Patients With AMI [Phase 4]
A Phase 4 clinical trial comparing ticagrelor and clopidogrel during reperfusion in patients with acute myocardial infarction, including tho…
-
CLINICAL_TRIALS trial_result · 2014-09-08Clinical Trial Update: Supporting Post Myocardial Infarction (MI) Risk Modification Intervention Via Telemedicine Evaluation [NA]
An administrative update on a Duke University–sponsored clinical trial evaluating a telemedicine intervention to modify risk after myocardia…
-
FDA approval · 2014-09-04FDA Approved: TRANDOLAPRIL — Supplemental Application (Epic Pharma, LLC)
FDA approved a supplemental application for Trandolapril tablets from Epic Pharma, LLC.
-
CLINICAL_TRIALS trial_result · 2014-09-03Clinical Trial Update: Ezetimibe In Addition To Atorvastatin Therapy On The Plaque Composition In Patients With Acute Myocardial Infarction. [Phase 4]
Phase 4 study evaluating whether adding ezetimibe to atorvastatin therapy changes plaque composition in patients with ST-segment elevation m…
-
CLINICAL_TRIALS trial_result · 2014-08-28Clinical Trial Update: Myocardial Ischemia and Transfusion Pilot [Phase 3]
A Phase 3 clinical trial update on a myocardial ischemia and transfusion pilot completed with results posted in 2014.
-
FDA approval · 2014-08-27FDA Approved: METOPROLOL TARTRATE — Original Application (Almaject, Inc.)
FDA approved Almaject, Inc.'s metoprolol tartrate as an original Abbreviated New Drug Application (ANDA), establishing a generic version of …
-
CLINICAL_TRIALS trial_result · 2014-08-25Clinical Trial Update: The Effect of Exercise Training on Cardiac Structure and Function [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating the effects of exercise training on cardiac structure and function in patients following myocardial infa…
-
CLINICAL_TRIALS research · 2014-08-19Clinical Trial Update: Drug-coated Balloon Versus Drug-eluting Stent in Acute Myocardial Infarction [NA]
A clinical trial update examining whether drug-coated balloons are comparable to drug-eluting stents for patients with acute myocardial infa…
-
CLINICAL_TRIALS trial_result · 2014-08-15Clinical Trial Update: Trial to Assess the Safety and Effects of Vorapaxar in Japanese Subjects With Acute Coronary Syndrome (P04772; MK-5348-016) [Phase 2]
Phase 2 trial assessing the safety and effects of Vorapaxar in Japanese subjects with acute coronary syndrome. The study reported results in…
-
CLINICAL_TRIALS trial_result · 2014-08-11Clinical Trial Update: Eptifibatide and ST Segment Resolution Following Primary PCI [Phase 3]
A Phase 3 clinical trial evaluating eptifibatide for ST-segment resolution after primary PCI in myocardial infarction has been terminated.
-
CLINICAL_TRIALS trial_result · 2014-08-01Clinical Trial Update: Post Marketing Surveillance to Monitor the Safety and Efficacy of Metalyse® in Korean Patients With Acute Myocardial Infarction
A completed post-marketing surveillance study in Korean patients assessed the safety and efficacy of Metalyse (tenecteplase) for acute myoca…
-
FDA approval · 2014-07-28FDA Approved: AMLODIPINE AND ATORVASTATIN — Supplemental Application (Prasco Laboratories)
The FDA approved a supplemental application from Prasco Laboratories for the fixed-dose combination of amlodipine and atorvastatin (amlodipi…
-
FDA approval · 2014-07-19FDA Approved: METOPROLOL TARTRATE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for metoprolol tartrate filed by Aurobindo Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2014-07-18Clinical Trial Update: Surveillance of Patients With Suspected Acute Myocardial Infarction That Receive Early Inhospital Thrombolysis With Metalyse
This clinical trial update reports a completed study of patients with suspected acute myocardial infarction who received early in-hospital t…
-
CLINICAL_TRIALS trial_result · 2014-07-16Clinical Trial Update: Observational Study of METALYSE® in Patients With Acute Myocardial Infarction In Russian Federation
This clinical trial update notes the completed observational study evaluating METALYSE in patients with acute myocardial infarction in the R…
-
CLINICAL_TRIALS trial_result · 2014-07-15Clinical Trial Update: Fixed Dose Combination Drug (Polypill)for Secondary Cardiovascular Prevention. [Phase 3]
Phase 3 trial results for a fixed-dose combination polypill for secondary cardiovascular prevention after myocardial infarction have been co…